176 related articles for article (PubMed ID: 9423923)
1. Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.
Karcz-Kubicha M; Jessa M; Nazar M; Plaznik A; Hartmann S; Parsons CG; Danysz W
Neuropharmacology; 1997 Oct; 36(10):1355-67. PubMed ID: 9423923
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
Karcz-Kubicha M; Wedzony K; Zajaczkowski W; Danysz W
J Neural Transm (Vienna); 1999; 106(11-12):1189-204. PubMed ID: 10651113
[TBL] [Abstract][Full Text] [Related]
3. GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
Karcz-Kubicha M; Lorenz B; Danysz W
Neuropharmacology; 1999 Jan; 38(1):109-19. PubMed ID: 10193902
[TBL] [Abstract][Full Text] [Related]
4. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.
Poleszak E; Wlaź P; Wróbel A; Fidecka S; Nowak G
Pharmacol Rep; 2008; 60(5):655-63. PubMed ID: 19066411
[TBL] [Abstract][Full Text] [Related]
5. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
[TBL] [Abstract][Full Text] [Related]
6. Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis.
Klodzińska A; Chojnacka-Wójcik E
Psychopharmacology (Berl); 2000 Oct; 152(2):224-8. PubMed ID: 11057527
[TBL] [Abstract][Full Text] [Related]
7. Anxioselective profile of glycineB receptor partial agonist, D-cycloserine, in plus-maze-naïve but not plus-maze-experienced mice.
Rodgers RJ; Howard K; Stewart S; Waring P; Wright FL
Eur J Pharmacol; 2010 Nov; 646(1-3):31-7. PubMed ID: 20727880
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
Bertoglio LJ; Carobrez AP
Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
[TBL] [Abstract][Full Text] [Related]
10. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
11. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
[TBL] [Abstract][Full Text] [Related]
12. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
13. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
14. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324.
Kotlinska J; Liljequist S
Psychopharmacology (Berl); 1998 Jan; 135(2):175-81. PubMed ID: 9497023
[TBL] [Abstract][Full Text] [Related]
15. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Wiley JL; Cristello AF; Balster RL
Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
[TBL] [Abstract][Full Text] [Related]
16. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
Bennett S; Gronier B
Eur J Pharmacol; 2005 Dec; 527(1-3):52-9. PubMed ID: 16307739
[TBL] [Abstract][Full Text] [Related]
17. D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze.
Moraes Ferreira VM; Morato GS
Alcohol Clin Exp Res; 1997 Dec; 21(9):1638-42. PubMed ID: 9438524
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
19. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality.
Danysz W; Parsons CG; Karcz-Kubicha M; Schwaier A; Popik P; Wedzony K; Lazarewicz J; Quack G
Amino Acids; 1998; 14(1-3):235-9. PubMed ID: 9871467
[TBL] [Abstract][Full Text] [Related]
20. Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats.
Wlaź P; Löscher W
Eur J Pharmacol; 1998 Jan; 342(1):39-46. PubMed ID: 9544790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
